je.st
news
Tag: vaccine
Mercks 9-Valent HPV Vaccine, GARDASIL9, Recommended by CDCs Advisory Committee on Immunization Practices for Females Aged 9-26 and Males Aged 9-21
2015-02-26 21:18:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Centers for Disease Control and Preventions (CDCs) Advisory Committee on Immunization Practices (ACIP) voted to include GARDASIL9 (Human Papillomavirus 9-valent Vaccine, Recombinant) in the recommendations for use of HPV vaccines. GARDASIL 9 has been added to the routine recommendations for vaccination of 11- and 12- year-old females and males. The vaccination series can be started at age nine. Language: English Contact: Media:Pamela Eisele, 267-305-3558Deb Wambold, 215-652-2913Investor:Justin Holko, 908-740-1879Amy Klug, 908-740-1898 Media Capsule: Please Activate Javascript !function(d, s, id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https',dt=new Date().getTime();if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+"://s3.amazonaws.com/contentcapsule.com/clients/Merck/tags/83723ae8-8ced-4eba-af3f-282064c0e25f_reg_frame.js?dt="+dt;fjs.parentNode.insertBefore(js,fjs);}}(document,"script","contentcapsule-embed-83723ae8-8ced-4eba-af3f-282064c0e25f"); Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: recommended
committee
practices
advisory
Vaccine approved for extended BVD respirtory disease protection
2015-02-19 22:30:53| Beef
Ask most veterinarians to take the long list of the beef cattle diseases they’re concerned about and cull it down to a short list, and bovine viral diarrhea (BVD) will be compete for the top two or three spots. That’s because BVD can affect your cattle in so many different ways—not the least of which is respiratory disease. And that’s before you consider the persistently infected (PI) problem. read more
Tags: protection
approved
extended
disease
Vaccine approved for extended BVD respirtory disease protection
2015-02-19 22:30:53| Beef
Ask most veterinarians to take the long list of the beef cattle diseases they’re concerned about and cull it down to a short list, and bovine viral diarrhea (BVD) will be compete for the top two or three spots. That’s because BVD can affect your cattle in so many different ways—not the least of which is respiratory disease. And that’s before you consider the persistently infected (PI) problem. read more
Tags: protection
approved
extended
disease
Novavax starts Ebola vaccine trial in humans
2015-02-12 16:18:38| Biotech - Topix.net
Novavax Inc has begun early-stage testing of its Ebola vaccine in humans, the company said, less than five months after entering the race to develop a shot for the deadly virus. After appearing to subside earlier this year, the number of new Ebola cases in West Africa has risen for the second week in a row, the World Health Organization said on Wednesday.
Tags: trial
starts
humans
vaccine
BIO Praises Vaccine Access, Certainty, and Innovation Act of 2015.
2015-02-12 14:31:20| Industrial Newsroom - All News for Today
BIO applauded introduction of Vaccine Access, Certainty, and Innovation Act of 2015 by noting how it would stimulate new vaccine research and improve patient access. In his statement, BIO President and CEO Jim Greenwood thanked Representatives Ellmers and Butterfield "for their leadership in authoring and sponsoring this important legislation." Greenwood also expressed enthusiastic anticipation regarding further work on said bill and other components of 21st Century Cures Initiative.
Tags: access
act
bio
innovation
Sites : [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] next »